MedTrace Logo

Myofascial Line Training Effects on Mobility and Endurance in Adolescent Football Players

NCT07699822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-07-13

No results posted yet for this study

Summary

This study compared the effects of two myofascial chain training programs - the Superficial Posterior Line (PL) and the Spiral Line (SL) - on joint mobility and myofascial isometric endurance in adolescent male football players. Thirty-eight licensed male players (ages 15-16) were enrolled in a randomized crossover trial consisting of two 6-week training phases (12 weeks total), with follow-up measurements at week 16. Each program was delivered twice weekly in 30-minute sessions alongside regular club training. Joint mobility was assessed using goniometry (shoulder flexion, hip flexion, hip extension, popliteal angle), and myofascial isometric endurance was evaluated using the Bunkie Test across five lines (APL, PPL, PSL, LSL, MSL).

Conditions

  • Athletic Performance Enhancement

Interventions

BEHAVIORAL

Superficial Posterior Line (PL) Myofascial Training

6-week myofascial training program targeting the posterior chain (plantar fascia, gastrocnemius, hamstrings, erector spinae). Two 30-minute sessions per week.

BEHAVIORAL

Spiral Line (SL) Myofascial Training

6-week myofascial training program targeting the spiral chain (rhomboids, serratus anterior, obliques, ITB, fibularis longus). Two 30-minute sessions per week.

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2025-09-01
Completion
2025-12-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07699822 on ClinicalTrials.gov